ZYUS Life Sciences Corporation Stock price
Equities
ZYUS
CA9899601095
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.02 CAD | -2.86% | -1.92% | +13.33% |
Sales 2023 * | 382K 282K | Sales 2024 * | 479K 354K | Capitalization | 72.26M 53.36M |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 * | 189 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 151 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 42.01% |
1 day | -2.86% | ||
1 week | -1.92% | ||
1 month | +4.08% | ||
3 months | +15.91% | ||
6 months | +0.99% | ||
Current year | +13.33% |
Managers | Title | Age | Since |
---|---|---|---|
Brent Zettl
FOU | Founder | 61 | 18-03-31 |
John Hyshka
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wayne Brownlee
BRD | Director/Board Member | 71 | 23-06-28 |
John Knowles
BRD | Director/Board Member | 68 | 20-08-31 |
Brent Zettl
FOU | Founder | 61 | 18-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 1.02 | -2.86% | 8,295 |
24-03-26 | 1.05 | +0.96% | 100 |
24-03-25 | 1.04 | -1.89% | 800 |
24-03-21 | 1.06 | +1.92% | 300 |
24-03-20 | 1.04 | -2.80% | 4,400 |
Delayed Quote Toronto S.E., March 27, 2024 at 03:56 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+13.33% | 53.18M | |
+9.29% | 45.97B | |
+52.73% | 43.93B | |
+7.56% | 42.34B | |
-8.78% | 28.27B | |
+18.43% | 27.18B | |
-21.86% | 19.44B | |
+14.34% | 13.83B | |
+32.41% | 12.4B | |
+4.97% | 11.45B |